Status:
COMPLETED
Therapeutic Thoracentesis for Patients With Congestive Heart Failure and Large Pleural Effusion
Lead Sponsor:
Taipei Medical University Hospital
Conditions:
Congestive Heart Failure
Transudative Pleural Effusion
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Transudative pleural effusions are a common manifestation of patients with congestive heart failure. Severe dyspnea and respiratory failure may develop in those with large effusions, which in general ...
Eligibility Criteria
Inclusion
- transudative pleural effusion established by the criteria of Light
- the effusion occupying at least half of one hemithorax shown on chest radiography
- symptoms of respiratory distress
- diagnosis of congestive heart failure
Exclusion
- severe uncontrolled coagulopathy
- unstable hemodynamics
- diagnosis of liver cirrhosis, chronic obstructive pulmonary disease,asthma and/or any parenchymal lung disease, such as pneumonia, fibrosis or malignancy.
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2009
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00629538
Start Date
March 1 2007
End Date
July 1 2009
Last Update
December 30 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei Medical University Hospital
Taipei, Taiwan, 110